Fewer patients with autoimmune disease are dying due to cardiovascular disease, but women remain at higher risk vs. men, ...

Nutrition is critical for combating chronic diseases in the United States, but research on optimal diets is inconsistent, ...

Adults with a mental illness experienced weight loss and glycemic benefits with use of a GLP-1 without worsening of mental ...

Dermatology patients living in the most disadvantaged neighborhoods were three times more likely to receive a diagnosis of ...

Heightened exposure levels to particulate matter before COVID-19 hospitalization raised the odds for poor outcomes in ...

Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

Immunoengineering, which has been beneficial to other medical specialties, could be used in the infectious diseases field to ...

Treatment with stimulants is unlikely to cause psychotic symptoms in children with ADHD, according to a new study published ...

When we are looking at the role of a mental health professional, we are bridging this gap between physical healing and ...

Annual universal depression screening for adolescents during primary care visits is cost effective, especially for certain ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.